Dr. Jeffrey Apter participated at CNS Summit in Florida, USA
Last week GCT President Dr. Jeffrey Apter attended the annual CNS summit in The Boca Raton Resort & Club Boca Raton, Florida, USA.
CNS Summit’s programs and initiatives are designated to shape the future of clinical trials and drug development. The Summit is known for its innovative content and format, as well as the strong emphasis on collaboration between leaders from pharmaceutical and biotech companies, research sites, and service companies to solve pressing challenges in drug development.
Over the years GCT has gained a great experience of conducting clinical trial in CNS field in Central-Eastern Europe and India. We are closely familiar with key opinion leaders in this therapeutic area, as well as experienced investigative sites and patient organizations and we will gladly apply this knowledge to assure the successful completion of your planned clinical program.
Updated: November 22, 2017